Clinical Trial Update: Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nabilone to promote sleep in adults with chronic non-malignant pain and insomnia; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Pain

Drugs mentioned

• CESAMET (nabilone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Pain, Insomnia | Phase 2 | Status: UNKNOWN